Bellartem Suspension, containing artemether and lumefantrine, is indicated for the treatment of uncomplicated malaria; it is contraindicated in patients with a history of hypersensitivity to its components, may cause side effects such as headache, dizziness, and gastrointestinal disturbances, and can interact with drugs that affect liver enzymes, potentially altering the metabolism of either medication.